Literature DB >> 7647793

Amyotrophic lateral sclerosis associated with homozygosity for an Asp90Ala mutation in CuZn-superoxide dismutase.

P M Andersen1, P Nilsson, V Ala-Hurula, M L Keränen, I Tarvainen, T Haltia, L Nilsson, M Binzer, L Forsgren, S L Marklund.   

Abstract

Recent reports have shown heterozygosity for some twenty different mutations in the CuZn-superoxide dismutase (CuZn-SOD) gene in familial amyotrophic lateral sclerosis (FALS), and analysed samples from patients have shown decreased enzymic activity. Here we report homozygosity for an exon 4 mutation, Asp90Ala in fourteen patients among four unrelated ALS families and four apparently sporadic ALS patients from Sweden and Finland. The erythrocyte CuZn-SOD activity is essentially normal. Our findings suggest that this CuZn-SOD mutation causes ALS by a gain of function rather than by loss, and that the Asp90Ala mutation is less detrimental than previously reported mutations.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7647793     DOI: 10.1038/ng0595-61

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  67 in total

Review 1.  Introduction to the minireviews series on mitochondrial matters in amyotrophic lateral sclerosis, Lou Gehrig’s disease.

Authors:  George H Sack
Journal:  J Bioenerg Biomembr       Date:  2011-12       Impact factor: 2.945

2.  Pathological characterization of astrocytic hyaline inclusions in familial amyotrophic lateral sclerosis.

Authors:  S Kato; H Hayashi; K Nakashima; E Nanba; M Kato; A Hirano; I Nakano; K Asayama; E Ohama
Journal:  Am J Pathol       Date:  1997-08       Impact factor: 4.307

3.  Evaluation of antioxidants, protein, and lipid oxidation products in blood from sporadic amyotrophic lateral sclerosis patients.

Authors:  P I Oteiza; O D Uchitel; F Carrasquedo; A L Dubrovski; J C Roma; C G Fraga
Journal:  Neurochem Res       Date:  1997-04       Impact factor: 3.996

4.  The epidemiology of CuZn-SOD mutations in Germany: a study of 217 families.

Authors:  Malessa Rabe; Ansgar Felbecker; Stefan Waibel; Peter Steinbach; Pia Winter; Ulrich Müller; Albert C Ludolph
Journal:  J Neurol       Date:  2010-03-23       Impact factor: 4.849

5.  Proteins that bind to misfolded mutant superoxide dismutase-1 in spinal cords from transgenic amyotrophic lateral sclerosis (ALS) model mice.

Authors:  Per Zetterström; Karin S Graffmo; Peter M Andersen; Thomas Brännström; Stefan L Marklund
Journal:  J Biol Chem       Date:  2011-04-14       Impact factor: 5.157

6.  A mechanism for low penetrance in an ALS family with a novel SOD1 deletion.

Authors:  L Zinman; H N Liu; C Sato; Y Wakutani; A F Marvelle; D Moreno; K E Morrison; K L Mohlke; J Bilbao; J Robertson; E Rogaeva
Journal:  Neurology       Date:  2009-03-31       Impact factor: 9.910

7.  Soluble misfolded subfractions of mutant superoxide dismutase-1s are enriched in spinal cords throughout life in murine ALS models.

Authors:  Per Zetterström; Heather G Stewart; Daniel Bergemalm; P Andreas Jonsson; Karin S Graffmo; Peter M Andersen; Thomas Brännström; Mikael Oliveberg; Stefan L Marklund
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-21       Impact factor: 11.205

Review 8.  The perplexing role of copper-zinc superoxide dismutase in amyotrophic lateral sclerosis (Lou Gehrig's disease).

Authors:  Soshanna Zittin Potter; Joan Selverstone Valentine
Journal:  J Biol Inorg Chem       Date:  2003-03-19       Impact factor: 3.358

9.  Characterization of intercostal muscle pathology in canine degenerative myelopathy: a disease model for amyotrophic lateral sclerosis.

Authors:  Brandie R Morgan; Joan R Coates; Gayle C Johnson; Alyssa C Bujnak; Martin L Katz
Journal:  J Neurosci Res       Date:  2013-09-16       Impact factor: 4.164

Review 10.  Mutant CuZn superoxide dismutase in motor neuron disease.

Authors:  M E Gurney; R Liu; J S Althaus; E D Hall; D A Becker
Journal:  J Inherit Metab Dis       Date:  1998-08       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.